Table 4.
Mutation analysis |
No. of patients during zinc sulphate therapy |
|
Without side effects | With side effects | |
Homozygous for p.H1069Q mutation | 16 | 3 |
Compound heterozygous for p.H1069Q mutation | 8 | 5 |
Carrier for p.H1069Q mutation | 4 | 1 |
Carrier for a mutation other than p.H1069Q | 0 | 5 |
Mutation other than p.H1069Q on two alleles | 2 | 2 |
Lack of data | 2 | 5 |